Filter
7632
Filtered Results: 7632
Text search:
number
of
patients
Featured
Recommendations
731
New Publications
1929
Language
Document type
No document type
4300
Studies & Reports
1174
Guidelines
1075
Manuals
385
Strategic & Response Plan
228
Fact sheets
168
Training Material
127
Situation Updates
98
Resource Platforms
24
Infographics
19
Online Courses
17
Brochures
15
Dashboards/Maps
1
Videos
1
Countries / Regions
India
433
Global
253
Kenya
212
South Africa
212
Sierra Leone
194
Liberia
178
Western and Central Europe
162
Ethiopia
152
Uganda
139
Nigeria
134
Africa
115
Malawi
114
Nepal
112
Latin America and the Carribbean
108
Tanzania
107
Zambia
97
Rwanda
96
Bangladesh
92
Myanmar / Burma
86
Ghana
85
Syria
82
Ukraine
79
Namibia
63
Philippines
57
Congo, Democratic Republic of
56
Eastern Europe
56
Russia
55
Guinea
54
Zimbabwe
48
West and Central Africa
48
South–East Asia Region
48
Lesotho
47
Cambodia
46
Mozambique
46
East and Southern Africa
45
Middle East and North Africa
44
Asia
43
South Sudan
41
Haiti
40
Germany
38
Indonesia
35
Senegal
34
Brazil
32
Botswana
31
Burkina Faso
30
Eastern Europe and Central Asia
29
Cameroon
27
Yemen
24
Benin
22
Eswatini/ Swaziland
21
Colombia
19
Venezuela
19
Pakistan
16
Western Pacific Region
16
USA
15
Madagascar
15
Mali
13
Central African Republic
13
Iraq
12
Afghanistan
12
Albania
12
Tajikistan
12
Thailand
11
Sudan
11
Peru
11
Georgia
11
Somalia
10
Lebanon
10
Sri Lanka
10
Jordan
9
Chile
9
Palestine
9
Southern Africa
9
Laos
9
Moldova
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Angola
8
Paraguay
8
North America
8
United Kingdom
8
China
7
North Macedonia
6
Bolivia
6
Armenia
6
Turkey
5
Chad
5
Argentina
5
Ecuador
5
Mexico
5
Kazakhstan
5
Jamaica
5
France
5
Guinea-Bissau
4
Togo
4
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Kyrgyzstan
4
Spain
4
Saudi Arabia
3
Niger
3
Singapore
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Greece
3
Libya
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Mauritius
3
Morocco
2
Egypt
2
Ireland
2
Switzerland
2
Burundi
2
Honduras
2
Guatemala
2
Other region
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Portugal
2
Malaysia
1
Mauritania
1
Austria
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2849
Clinical Guidelines
692
Public Health
421
Women & Child Health
297
Key Resources
234
Capacity Building
163
Pharmacy & Technologies
102
Annual Report MEDBOX
2
Toolboxes
COVID-19
848
Mental Health
613
HIV
603
TB
496
Ebola
315
Caregiver
257
Rapid Response
255
AMR
248
NTDs
220
Conflict
180
NCDs
175
Pharmacy
166
Disability
146
Refugee
123
Planetary Health
122
Global Health Education
76
Cholera
64
Natural Hazards
58
Zika
49
Specific Hazards
44
Health Financing Toolbox
41
Polio
38
Social Ethics
26
Typhoon
3
South Sudan
1
Health Financing
1
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy ... “re-purposed” drugs that have been widely used to treat other infections but are also showing promise in the treatment of DR-TB, including linezolid and clofazimine. This special supplemental guide has been developed for nurses, because it is essential that nurses be provided with material that maximizes their ability to provide optimal support to patients who are receiving new and re-purposed drugs
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmissio...
The second edition of the WHPCA Global Atlas of Palliative Care was launched during World Hospice & Palliative Care Day 10 October. The Atlas is an update ... the original WHPCA/WHO Global Atlas of Palliative care at the end of life published in 2014. It is full of useful facts and figures to support palliative care advocacy and development. In this edition we have switched from using the WHO methodology for need for palliative care to the evolving Lancet Commission on Palliative Care and Pain Relief methodology. As a result the number of people needing palliative care has gone from 40 million per year to almost 57 million and more accurately reflects the need for palliative care globally models of palliative care worldwide? What resources are devoted to palliative care? What is the way forward?
Formularies are lists of antibiotics that are suggested for certain healthcare settings. In developing a recommended formulary, countries should consider the needs of ... and facilities where they receive care. For example, clinicians in rural or primary health centers may need wide access to first-line antibiotics (e.g., penicillin, ampicillin, TMP-SMX), but last resort antibiotics such as carbapenems or colistin might be limited to tertiary care hospitals. Efforts to create antibiotic formularies may be linked to efforts within countries to create or update essential medicine lists (EML).
Health Evidence Network Synthesis Report, No. 47
The increasing number of refugees, asylum seekers and irregular migrants poses a challenge for mental health services in Europe. This review found t...
A healthcare worker manual. 2nd edition
The development of this National Manual for the Management of HIV-related Opportunistic Infections and Conditions for use by health care workers at the front...
Introduction The novel Coronavirus (nCoV) epidemic in 2019 -2020 has recently emerged. The route of transmission is not totally known, although it is known that it can spread from person to person, and local health care systems may be ill-equipped t...
Community use of face masks
recommended
Update 1 October 2020.
This document provides guidance to Member States on the effective use of face masks/coverings in the community by individuals without COVID-19 symptoms in order to reduce potential transmission ... SARS-CoV-2.a It also provides advice on the use of masks during home care for patients with COVID-19.
Supporting the continuity of health and nutrition services in the context of COVID-19 in refugee settings
recommended
The 2014–2015 Ebola outbreak was catastrophic in West Africa but the indirect impact of increasing the mortality rates of other conditions was also substantial. The increased ... of deaths caused by malaria, HIV/AIDS, and tuberculosis attributable to health system failures exceeded deaths from Ebola.
With a relatively limited COVID-19 caseload, health systems may have the capacity to maintain routine service delivery in addition to managing COVID-19 cases. When caseloads are high, and/or health workers are directly affected, strategic adaptations are required to ensure that increasingly limited resources provide maximum benefit for the refugees and surrounding host population. The following are key considerations for UNHCR operations on prioritized health care services in the event of a COVID-19 outbreak. These are based on WHO Guidance for Maintaining Essential Health Services and UNHCR guidance for operations and where relevant operation or site level outbreak preparedness and response plans.
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care ... COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. No further updates to the previous existing recommendations were made in this latest version.
This updated (fifth) version contains 16 new recommendations for the rehabilitation of adults with post COVID-19 condition (see Chapter 24)
This updated (fourth) version contains three new recommendations regarding hospitalized patients with severe or critical COVID-19
In December 2019 a novel coronavirus (2019-nCoV) was identified as the causative agent of a severe acute respiratory illness among people exposed in a seafood market in Wuhan, China; • Human-to-human transmission has been documented, including in ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerab...
Quality of care in fragile, conflict-affected and vulnerable settings: tools and resources compendium
recommended
This compendium represents a curated, pragmatic and non-prescriptive collection of tools and resources to support the implementation of interventions to improve quality ... care in such contexts. Relevant tools and resources are listed under five areas: Ensuring access and basic infrastructure for quality; shaping the system environment; reducing harm; improving clinical care; and engaging and empowering patients, families and communities.
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr...
Because of the limited access to more powerful diagnostic tools, there is a paucity of data regarding the burden of fungal infections in Burkina Fa...
This toolkit is designed to help you plan and implement a Patient Navigation program with the best chance of reducing health disparities and improving health outcomes for your .... It contains evidence-based and experience-based examples, case studies, practical tools, and resources to help you:
1. Establish an evidence-based patient navigation program tailored to reduce barriers for your patients
2. Incorporate best practices to enhance current patient navigation programs or services
3. Implement a patient navigation model to address any targeted medical condition
where disparities exist
4. Hire, prepare, supervise, support and retain effective Patient Navigators
5. Navigate patients who experience health disparities
6. Evaluate patient navigation programs with the aim of continuous quality
improvement
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted b...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number ... Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from two to four; and the recommendation for intralesional antimonials is now strong. For mucosal leishmaniasis there is now a strong recommendation for use of pentavalent antimonials with or without oral pentoxifylline. For visceral leishmaniasis, the strong recommendations for use of pentavalent antimonials and amphotericin B deoxycholate are now conditional.
Patient safety assessment manual
recommended
3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third e...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula ... Member States. Specific treatment is not available, and there is no vaccine for the prevention of chikungunya fever. It has therefore become imperative to develop guidelines, based on the limited clinical experience gathered from managing patients so far, for appropriate management of patients in communities and in health facilities. Experts engaged in managing patients with chikungunya fever in the Region were brought together by the WHO Regional Office for South-East Asia to outline guidelines for managing various situations and stages of the disease.
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is no vaccine for the prevention of chikungunya fever. It has therefore become imperative to develop guidelines, based on the limited clinical experience gathered from managing patients so far, for appropriate management of patients in communities and in health facilities. Experts engaged in managing patients with chikungunya fever in the Region were brought together by the WHO Regional Office for South-East Asia to outline guidelines for managing various situations and stages of the disease. This publication is the end result of that exercise and is intended to assist health-care providers in planning and implementing appropriate care to patients with chikungunya fever according to their actual clinical conditions
